Biomarkers and Therapeutics for Autism Spectrum Disorders
Invention type: Technology
/
Case number: #13589P
The invention relates to methods for diagnosis and treatment of autism spectrum disorders, particularly for autism spectrum disorders characterized by increased head size (circumference) and deficits in social behavior.
Researchers
Mriganka Sur
/
Damon Page
Departments: Department of Brain and Cognitive Sciences
Technology Areas: Biotechnology: DNA & RNA Editing / Therapeutics: Nucleic Acids, Proteins & Antibodies, Small Molecules
Impact Areas: Healthy Living
-
diagnosis of autism spectrum disorders and its treatment with an antagonist or inhibitor of the 5-ht2c receptor signaling pathway
United States of America | Granted | 9,730,945 -
diagnosis of autism spectrum disorders and its treatment with an antagonist or inhibitor of the 5-ht2c receptor signaling pathway
United States of America | Granted | 8,940,732 -
diagnosis and treatment of autism spectrum disorders
Japan | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.